The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Sengul, D.; Sengul, I.; Ustun, H. Dedifferentiated Liposarcoma of the Left Thigh: A Rare Case. Med. Arch. 2019, 73, 121–122. [Google Scholar] [CrossRef] [PubMed]
- De Vita, A.; Mercatali, L.; Recine, F.; Pieri, F.; Riva, N.; Bongiovanni, A.; Liverani, C.; Spadazzi, C.; Miserocchi, G.; Amadori, D.; et al. Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. Onco. Targets Ther. 2016, 9, 6233–6246. [Google Scholar] [CrossRef] [PubMed]
- Henze, J.; Bauer, S. Liposarcomas. Hematol. Oncol. Clin. N. Am. 2013, 27, 939–955. [Google Scholar] [CrossRef]
- Kim, D.W.; Jee, Y.S. Solitary metastasis of myxoid liposarcoma from the thigh to intraperitoneum: A case report. World J. Surg. Oncol. 2019, 17, 172. [Google Scholar] [CrossRef] [PubMed]
- Thway, K. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review. Semin. Diagn. Pathol. 2019, 36, 112–121. [Google Scholar] [CrossRef]
- Gahvari, Z.; Parkes, A. Dedifferentiated Liposarcoma: Systemic Therapy Options. Curr. Treat. Options. Oncol. 2020, 21, 15. [Google Scholar] [CrossRef]
- Crago, A.M.; Dickson, M.A. Liposarcoma: Multimodality Management and Future Targeted Therapies. Surg. Oncol. Clin. N. Am. 2016, 25, 761–773. [Google Scholar] [CrossRef]
- Kammerer-Jacquet, S.F.; Thierry, S.; Cabillic, F.; Lannes, M.; Burtin, F.; Henno, S.; Dugay, F.; Bouzillé, G.; Rioux-Leclercq, N.; Belaud-Rotureau, M.A.; et al. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: Utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. Hum. Pathol. 2017, 59, 34–40. [Google Scholar] [CrossRef]
- Kilpatrick, S.E. Dedifferentiated Liposarcoma: A Comprehensive Historical Review with Proposed Evidence-based Guidelines Regarding a Diagnosis in Need of Further Clarification. Adv. Anat. Pathol. 2021, 28, 426–438. [Google Scholar] [CrossRef]
- Child, J.R.; Young, C.R.; Amini, B. Liposarcoma of the thigh with mixed calcification and ossification. Radiol. Case Rep. 2016, 11, 217–221. [Google Scholar] [CrossRef]
- Lu, J.; Wood, D.; Ingley, E.; Koks, S.; Wong, D. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma. Mol. Biol. Rep. 2021, 48, 3637–3647. [Google Scholar] [CrossRef]
- Yu, J.S.E.; Colborne, S.; Hughes, C.S.; Morin, G.B.; Nielsen, T.O. The FUS-DDIT3 Interactome in Myxoid Liposarcoma. Neoplasia 2019, 21, 740–751. [Google Scholar] [CrossRef] [PubMed]
- Dürr, H.R.; Rauh, J.; Baur-Melnyk, A.; Knösel, T.; Lindner, L.; Roeder, F.; Jansson, V.; Klein, A. Myxoid liposarcoma: Local relapse and metastatic pattern in 43 patients. BMC Cancer 2018, 18, 304. [Google Scholar] [CrossRef] [PubMed]
- Pink, D.; West, A.; Andreou, D. Systemic Therapy Options for Locally Advanced and Metastatic Myxoid, Dedifferentiated and Pleomorphic Liposarcoma. Zentralbl. Chir. 2020, 145, 160–167. (In German) [Google Scholar] [CrossRef] [PubMed]
- Lee, A.T.J.; Thway, K.; Huang, P.H.; Jones, R.L. Clinical and Molecular Spectrum of Liposarcoma. J. Clin. Oncol. 2018, 36, 151–159. [Google Scholar] [CrossRef]
- Tyler, R.; Wanigasooriya, K.; Taniere, P.; Almond, M.; Ford, S.; Desai, A.; Beggs, A. A review of retroperitoneal liposarcoma genomics. Cancer Treat Rev. 2020, 86, 102013. [Google Scholar] [CrossRef]
- Mantilla, J.G.; Ricciotti, R.W.; Chen, E.Y.; Liu, Y.J.; Hoch, B.L. Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma. Mod. Pathol. 2019, 32, 585–592. [Google Scholar] [CrossRef]
- 1Mariño-Enríquez, A.; Hornick, J.L.; Dal Cin, P.; Cibas, E.S.; Qian, X. Dedifferentiated liposarcoma and pleomorphic liposarcoma: A comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Cancer Cytopathol. 2014, 122, 128–137. [Google Scholar] [CrossRef]
- Weingertner, N.; Neuville, A.; Chibon, F.; Ray-Coquard, I.; Marcellin, L.; Ghnassia, J.P. Myxoid liposarcoma with heterologous components: Dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report. Appl. Immunohistochem. Mol. Morphol. 2015, 23, 230–235. [Google Scholar] [CrossRef]
- Tariq, H.; Sarfraz, T.; Saeed, I. Myxoid Liposarcoma with Cartilagenous Differentiation. J. Coll. Physicians Surg. Pak. 2020, 30, 1096–1098. [Google Scholar] [CrossRef]
- Kim, H.; Hwangbo, W.; Ahn, S.; Kim, S.; Kim, I.; Kim, C.H. Myxoid liposarcoma with cartilaginous differentiation: A case study with cytogenetical analysis. Korean J. Pathol. 2013, 47, 284–288. [Google Scholar] [CrossRef] [PubMed]
- Tajima, S.; Koda, K. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: Report of a case and review of the literature. Med. Mol. Morphol. 2017, 50, 112–116. [Google Scholar] [CrossRef] [PubMed]
- Sioletic, S.; Dal Cin, P.; Fletcher, C.D.; Hornick, J.L. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: Analysis of 56 cases. Histopathology 2013, 62, 287–293. [Google Scholar] [CrossRef] [PubMed]
- Peck, T.; Gervasio, K.A.; Zhang, P.J.L.; Shields, C.L.; Lally, S.E.; Eagle, R.C., Jr.; Milman, T. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Myxoid Stroma in a Hereditary Retinoblastoma Survivor. Ocul. Oncol. Pathol. 2020, 6, 79–86. [Google Scholar] [CrossRef]
- Campbell, G.S.; Lawrence, T.J.; Porter, S.E.; Rezeanu, L. Primary dedifferentiated liposarcoma of the axilla arising in a mixed, well-differentiated and myxoid liposarcoma. J. Radiol. Case Rep. 2012, 6, 9–16. [Google Scholar] [CrossRef]
- Scapa, J.V.; Cloutier, J.M.; Raghavan, S.S.; Peters-Schulze, G.; Varma, S.; Charville, G.W. DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma. Am. J. Surg. Pathol. 2021, 45, 230–239. [Google Scholar] [CrossRef]
- Creytens, D. What’s new in adipocytic neoplasia? Virchows Arch. 2020, 476, 29–39. [Google Scholar] [CrossRef]
- Kobayashi, A.; Sakuma, T.; Fujimoto, M.; Jimbo, N.; Hirose, T. Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma. Appl. Immunohistochem. Mol. Morphol. 2019, 27, 758–763. [Google Scholar] [CrossRef]
- Song, M.J.; Cho, K.J.; Lee, J.S.; Song, J.S. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas. Appl. Immunohistochem. Mol. Morphol. 2017, 25, 712–719. [Google Scholar] [CrossRef]
- Gong, L.H.; Liu, W.F.; Ding, Y.; Li, L.; Zhang, M.; Sun, X.Q.; Huang, X.Y. Dedifferentiated liposarcoma of extremities: A clinicopathologic analysis. Zhonghua Bing Li Xue Za Zhi 2018, 47, 511–516. (In Chinese) [Google Scholar]
- Zajicek, A.K.; Bridge, J.A.; Akers, J.W.; McGarry, S.V.; Walker, C.W. Dedifferentiated liposarcoma of the lower extremity with low-grade dedifferentiation and low-grade osteosarcomatous component. Skeletal. Radiol. 2017, 46, 265–271. [Google Scholar] [CrossRef] [PubMed]
- Dantey, K.; Schoedel, K.; Yergiyev, O.; Bartlett, D.; Rao, U.N.M. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas. Hum. Pathol. 2017, 66, 86–92. [Google Scholar] [CrossRef] [PubMed]
- Redroban, L.; Montalvo, N. Vulvar Myxoid Liposarcoma, an Extremely Rare Diagnosis: A Case Report and Review of Literature. Int. J. Gynecol. Pathol. 2019, 38, 17–20. [Google Scholar] [CrossRef] [PubMed]
- Cappellesso, R.; d’Amore, E.S.; Dall’Igna, P.; Guzzardo, V.; Vassarotto, E.; Rugge, M.; Alaggio, R. Immunohistochemical expression of p16 in lipoblastomas. Hum. Pathol. 2016, 47, 64–69. [Google Scholar] [CrossRef]
- Arici, A.; Ozgur, T.; Ugras, N.; Yalcinkaya, U. Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification. Indian. J. Cancer 2013, 50, 164–169. [Google Scholar] [CrossRef]
- Kural Mangit, E.; Boustanabadimaralan Düz, N.; Dinçer, P. A cytoplasmic escapee: Desmin is going nuclear. Turk. J. Biol. 2021, 45, 711–719. [Google Scholar] [CrossRef]
- Stocker, M.; Le Nail, L.R.; De Belenet, H.; Wunder, J.S.; Andrulis, I.L.; Gokgoz, N.; Levy, N.; Mattei, J.C.; Olschwang, S. Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development. Am. J. Cancer Res. 2021, 11, 3271–3284. [Google Scholar]
- Ståhlberg, A.; Kåbjörn Gustafsson, C.; Engtröm, K.; Thomsen, C.; Dolatabadi, S.; Jonasson, E.; Li, C.Y.; Ruff, D.; Chen, S.M.; Åman, P. Normal and functional TP53 in genetically stable myxoid/round cell liposarcoma. PLoS ONE 2014, 9, e113110. [Google Scholar] [CrossRef]
- Keung, E.Z.; Lazar, A.J.; Torres, K.E.; Wang, W.L.; Cormier, J.N.; Ashleigh Guadagnolo, B.; Bishop, A.J.; Lin, H.; Hunt, K.K.; Bird, J.; et al. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 2018, 18, 913. [Google Scholar] [CrossRef]
- Torabi, A.; Amaya, C.N.; Wians, F.H., Jr.; Bryan, B.A. PD-1 and PD-L1 expression in bone and soft tissue sarcomas. Pathology 2017, 49, 506–513. [Google Scholar] [CrossRef]
- Ratan, R.; Patel, S.R. Chemotherapy for soft tissue sarcoma. Cancer 2016, 122, 2952–2960. [Google Scholar] [CrossRef] [PubMed]
- Tong, Q.; Dalgin, G.; Xu, H.; Ting, C.N.; Leiden, J.M.; Hotamisligil, G.S. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 2000, 290, 134–138. [Google Scholar] [CrossRef] [PubMed]
- Wajant, H. Therapeutic targeting of CD70 and CD27. Expert Opin. Ther. Targets 2016, 20, 959–973. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ciongariu, A.-M.; Dumitru, A.-V.; Cîrstoiu, C.; Crețu, B.; Sajin, M.; Țăpoi, D.-A.; Ciobănoiu, A.-D.; Bejenariu, A.; Marin, A.; Costache, M. The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review. Medicina 2023, 59, 967. https://doi.org/10.3390/medicina59050967
Ciongariu A-M, Dumitru A-V, Cîrstoiu C, Crețu B, Sajin M, Țăpoi D-A, Ciobănoiu A-D, Bejenariu A, Marin A, Costache M. The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review. Medicina. 2023; 59(5):967. https://doi.org/10.3390/medicina59050967
Chicago/Turabian StyleCiongariu, Ana-Maria, Adrian-Vasile Dumitru, Cătălin Cîrstoiu, Bogdan Crețu, Maria Sajin, Dana-Antonia Țăpoi, Aminia-Diana Ciobănoiu, Adrian Bejenariu, Andrei Marin, and Mariana Costache. 2023. "The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review" Medicina 59, no. 5: 967. https://doi.org/10.3390/medicina59050967